| Jeffry S Lester, MD | |
|
104 E Shurden Industrial Blvd, Henryetta, OK 74437-7323 | |
| (918) 652-9614 | |
| (918) 652-4831 |
| Full Name | Jeffry S Lester |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 49 Years |
| Location | 104 E Shurden Industrial Blvd, Henryetta, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881723872 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 10800 (Oklahoma) | Secondary |
| 207Q00000X | Family Medicine | 10800 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Great Plains Regional Medical Center | Elk city, OK | Hospital |
| Hillcrest Hospital Henryetta | Henryetta, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Farmers Union Hospital Association | 7517949415 | 37 |
News Archive
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive results from the pivotal trial of single-agent brentuximab vedotin (SGN-35) in relapsed or refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate targeted to CD30, a defining marker of Hodgkin lymphoma.
Today begins the first phase of Obamacare's big test. The Obama administration has spent months and millions of dollars promising people great benefits from the new government-run health insurance exchanges. Now Americans will see for themselves. ... Instead of lower health care costs and better access to care, here are four reasons for the buyer to beware (Sen. John Barrasso, 10/1).
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
Tiny, implantable computers that would restore brain function lost to disease or injury is the goal of University of Washington research recently funded by a $1 million, three-year grant from the W.M. Keck Foundation.
› Verified 6 days ago
| Entity Name | Farmers Union Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184639122 PECOS PAC ID: 7517949415 Enrollment ID: O20040603001383 |
News Archive
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive results from the pivotal trial of single-agent brentuximab vedotin (SGN-35) in relapsed or refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate targeted to CD30, a defining marker of Hodgkin lymphoma.
Today begins the first phase of Obamacare's big test. The Obama administration has spent months and millions of dollars promising people great benefits from the new government-run health insurance exchanges. Now Americans will see for themselves. ... Instead of lower health care costs and better access to care, here are four reasons for the buyer to beware (Sen. John Barrasso, 10/1).
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
Tiny, implantable computers that would restore brain function lost to disease or injury is the goal of University of Washington research recently funded by a $1 million, three-year grant from the W.M. Keck Foundation.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffry S Lester, MD 104 E Shurden Industrial Blvd Ste A, Henryetta, OK 74437-7323 Ph: (580) 225-2513 | Jeffry S Lester, MD 104 E Shurden Industrial Blvd, Henryetta, OK 74437-7323 Ph: (918) 652-9614 |
News Archive
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive results from the pivotal trial of single-agent brentuximab vedotin (SGN-35) in relapsed or refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate targeted to CD30, a defining marker of Hodgkin lymphoma.
Today begins the first phase of Obamacare's big test. The Obama administration has spent months and millions of dollars promising people great benefits from the new government-run health insurance exchanges. Now Americans will see for themselves. ... Instead of lower health care costs and better access to care, here are four reasons for the buyer to beware (Sen. John Barrasso, 10/1).
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
Tiny, implantable computers that would restore brain function lost to disease or injury is the goal of University of Washington research recently funded by a $1 million, three-year grant from the W.M. Keck Foundation.
› Verified 6 days ago
Azhar Shakeel, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Dewey Bartlett & Main, Henryetta, OK 74023 Phone: 918-650-1323 Fax: 918-650-1100 | |
Wesley E Parkhurst Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 617 W Trudgeon St, Henryetta, OK 74437 Phone: 918-652-4400 Fax: 918-652-9869 | |
Audie Granville Swinney, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 28870 South Dewey Bartlett Ave, Henryetta, OK 74437 Phone: 918-652-2513 Fax: 918-652-7884 | |
Dr. Michael Terence Cain, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2401 W Main St, Henryetta, OK 74437 Phone: 918-652-9650 Fax: 918-652-7827 | |
Gary D Lovell, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1102 W Main St, Henryetta, OK 74437 Phone: 918-652-9614 Fax: 918-652-4831 | |
Raffi Djevalikian, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Dewey Bartlett & Main, Henryetta, OK 74437 Phone: 918-650-1301 Fax: 918-650-0568 |